Comparative review of novel model‐assisted designs for phase I clinical trials

Heng Zhou, Thomas A. Murray, Haitao Pan, Ying Yuan

Type: Review

Publication Date: 2018-04-22

Citations: 68

DOI: https://doi.org/10.1002/sim.7674

View Publication

Locations

PubMed - View
Statistics in Medicine - View

Similar Works

Action	Title	Year	Authors
+	Accuracy, Safety, and Reliability of Novel Phase I Trial Designs	2018	Heng Zhou Ying Yuan Lei Nie
+	Evaluating the effects of design parameters on the performances of phase I trial designs	2019	Angela Y. Zhu Wei‐Ting Hwang Yimei Li
+	Data from Accuracy, Safety, and Reliability of Novel Phase I Trial Designs	2023	Heng Zhou Ying Yuan Lei Nie
+	Data from Accuracy, Safety, and Reliability of Novel Phase I Trial Designs	2023	Heng Zhou Ying Yuan Lei Nie
+	Model-Assisted Designs Considering Toxicity Alone	2019	Takashi Daimon Akihiro Hirakawa Shigeyuki Matsui
+ PDF Chat	Performance of toxicity probability interval based designs in contrast to the continual reassessment method	2016	Bethany J. Horton Nolan A. Wages Mark R. Conaway
+ PDF Chat	Incorporating historical information to improve phase I clinical trial designs	2020	Yanhong Zhou J. Jack Lee Shunguang Wang Stuart Bailey Ying Yuan
+	Incorporating historical information to improve phase I clinical trial designs	2020	Yanhong Zhou J.Jack Lee Shunguang Wang Stuart Bailey Ying Yuan
+ PDF Chat	The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies	2024	Codruța Chiuzan Hakim‐Moulay Dehbi
+	Introduction to Phase I Dose-Finding Clinical Trials	2023	Haitao Pan Ying Yuan
+	Phase I Cancer Clinical Trial Design: Single and Combination Agents	2018	Ying Yuan Heng Zhou Yanhong Zhou
+	Incorporating historical information to improve phase I clinical trials	2021	Yanhong Zhou J. Jack Lee Shunguang Wang Stuart Bailey Ying Yuan
+	Phase I clinical trials in oncology: A review of the old and a look at the new.	2017	Bryan Fellman Kenneth R. Hess
+ PDF Chat	On the relative efficiency of model-assisted designs: a conditional approach	2019	Ruitao Lin Ying Yuan
+ PDF Chat	Overview of model-assisted design for phase I dose-finding trials in oncology	2022	Koichi Hashizume Kentaro Takeda Hiroyuki Sato Akihiro Hirakawa Takashi Sozu
+	Checkerboard: a Bayesian efficacy and toxicity interval design for phase I/II dose-finding trials	2020	Jun Yin Ying Yuan
+	Comparative review of novel model‐assisted designs for phase I/II clinical trials	2024	Haolun Shi Ruitao Lin Xiaolei Lin
+	Data from Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials	2023	Fangrong Yan Sumithra J. Mandrekar Ying Yuan
+	Data from Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials	2023	Fangrong Yan Sumithra J. Mandrekar Ying Yuan
+	Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials	2016	Ying Yuan Kenneth R. Hess Susan G. Hilsenbeck Mark R. Gilbert

Works That Cite This (59)

Action	Title	Year	Authors
+	Shotgun-2: A Bayesian phase I/II basket trial design to identify indication-specific optimal biological doses	2022	Xin Chen Jingyi Zhang Liyun Jiang Fangrong Yan
+ PDF Chat	Time-to-event model-assisted designs for dose-finding trials with delayed toxicity	2019	Ruitao Lin Ying Yuan
+ PDF Chat	Overview of model-assisted design for phase I dose-finding trials in oncology	2022	Koichi Hashizume Kentaro Takeda Hiroyuki Sato Akihiro Hirakawa Takashi Sozu
+ PDF Chat	A straightforward meta‐analysis approach for oncology phase I dose‐finding studies	2022	Christian Röver Moreno Ursino Tim Friede Sarah Zohar
+ PDF Chat	A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials	2023	Zhaohang Li Ze Xu Aijun Zhang Guanpeng Qi Zuojing Li
+	Evaluating the effects of design parameters on the performances of phase I trial designs	2019	Angela Y. Zhu Wei‐Ting Hwang Yimei Li
+	Enhancement of Bayesian optimal interval design by accounting for overdose and underdose errors trade-offs	2023	Ryo Sadachi Hiroyuki Sato Takeo Fujiwara Akihiro Hirakawa
+	Accuracy, Safety, and Reliability of Novel Phase I Trial Designs	2018	Heng Zhou Ying Yuan Lei Nie
+	Comparison of design methods for a safety run-in phase of a phase II clinical trial	2023	Lingyun Ji Todd A. Alonzo
+	Hybrid continuous reassessment method with overdose control for safer dose escalation	2023	Debopriya Ghosh Hong Xie Liangcai Zhang Fei Chen Surya Mohanty Xiang Li

Works Cited by This (30)

Action	Title	Year	Authors
+	Bayesian optimal interval design for dose finding in drug-combination trials	2015	Ruitao Lin Guosheng Yin
+	The bivariate continual reassessment method	2002	Thomas M. Braun
+	The Accelerated Biased Coin Up-and-Down Design in Phase I Trials	2004	Mario Stylianou Dean Follmann
+	Statistical Inference under Order Restrictions (The Theory and Application of Isotonic Regression)	1973	I. Vincze R. E. Barlow D. J. Bartholomew J. M. Bremner H. D. Brunk
+ PDF Chat	Continual Reassessment Method for Partial Ordering	2011	Nolan A. Wages Mark R. Conaway John O’Quigley
+ PDF Chat	Bayesian optimal interval designs for phase I clinical trials	2014	Suyu Liu Ying Yuan
+	Some practical problems in implementing randomization	2010	Matt Downs Kathryn Tucker Heidi Christ‐Schmidt Janet Wittes
+	Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials	2009	Guosheng Yin Ying Yuan
+ PDF Chat	Critical aspects of the Bayesian approach to phase I cancer trials	2008	Beat Neuenschwander Michael Branson Thomas Gsponer
+	Cancer phase I clinical trials: efficient dose escalation with overdose control	1998	James S. Babb André Rogatko Shelemyahu Zacks